1,881 Shares in Humana Inc. $HUM Purchased by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,881 shares of the insurance provider’s stock, valued at approximately $747,000.

Several other institutional investors have also added to or reduced their stakes in the company. Montag A & Associates Inc. increased its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. Fideuram Asset Management Ireland dac bought a new position in shares of Humana during the 4th quarter valued at approximately $27,000. Trust Co. of Vermont purchased a new position in shares of Humana in the second quarter valued at $28,000. Reflection Asset Management purchased a new position in shares of Humana in the fourth quarter valued at $29,000. Finally, Bogart Wealth LLC increased its position in Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on HUM. Leerink Partners upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective for the company in a research report on Thursday, July 30th. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a report on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $405.00 price target on shares of Humana in a report on Thursday, July 30th. Truist Financial lifted their price target on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, Royal Bank Of Canada boosted their price objective on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $395.22.

Humana Stock Down 0.6%

Shares of HUM opened at $382.13 on Wednesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The business has a fifty day moving average of $382.93 and a 200 day moving average of $278.32. The company has a market cap of $45.89 billion, a PE ratio of 36.15, a P/E/G ratio of 2.23 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter in the previous year, the business posted $6.27 earnings per share. The business’s revenue was up 26.2% compared to the same quarter last year. On average, sell-side analysts expect that Humana Inc. will post 9.08 EPS for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.